Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

3M Company Faces Mounting Lawsuits Over PFAS, Chemical Firefighting Foams

The 3M Company is facing a growing number of legal claims over PFAS, a group of allegedly toxic chemicals found in some firefighting foams. PFAS: The “Forever Chemicals” Polyfluoroalkyl substances, or PFAS, are manmade chemicals used to manufacture dozens of products, … Continue reading

Proton Pump Inhibitor Lawsuit Trials to Begin November 2021

The federal court overseeing thousands of lawsuits alleging Nexium and other proton pump inhibitors caused serious kidney complications has set a date for the litigation’s first bellwether trial. According to a Case Management Order issued in the U.S. District Court, … Continue reading

Breast Implant Cancer Lawsuits Progress, as Court Convenes First Case Management Conference

Lawsuits involving Allergan, Inc.’s Biocell textured breast implants are moving forward in the U.S. District Court, District of New Jersey, where an initial Case Management Conference was convened on January 13th. Plaintiffs Counsel to Propose Leadership Structure According to a … Continue reading

FDA Warning Alert: Belviq Weight Loss Drug May Increase Cancer Risk

The U.S. Food & Drug Administration (FDA) is investigating a possible link between the weight loss drug Belviq and an increased risk of cancer. About Belviq and Belviq XR Belviq and Belviq XR (lorcaserin) are indicated for use with a … Continue reading

Feinberg Optimistic for Monsanto Roundup Settlement

The prominent attorney tapped to lead Monsanto Roundup settlement talks is growing increasingly confident that the massive cancer litigation will be resolved. “There are talks with various lawyers around the nation who have significant inventories of Roundup cases,” Kenneth Feinberg … Continue reading

New York State Targets PFAS in Firefighting Foam

New York State is preparing to restrict the use of certain firefighting foams because of toxic chemicals that could potentially contaminate groundwater. Firefighting Foam and PFAS For decades, chemical firefighting foams (aqueous film-forming foam or AFFF) have been used in … Continue reading

Zantac Lawsuit News: Three Drug Makers Recall NDMA-Contaminated Antacids

Three pharmaceutical companies are recalling antacid medications due to concerns that the drugs might be contaminated with a potentially cancer-causing impurity called N-Nitrosodimethylamine, or NDMA. About the Latest Antacid Recalls According to the U.S. Food & Drug Administration (FDA), two … Continue reading

New York Lawmaker Wants to Extend Child Victims Act Filing Window

Nearly a year after the landmark passage of the Child Victims Act, a New York State lawmaker has proposed extending the one-year filing window that’s already allowed hundreds of alleged survivors to pursue decades-old sexual abuse claims. 1,300+ Child Victims … Continue reading

Federal Court Overseeing Allergan Breast Implant Lawsuits Issues First Case Management Order

The federal multidistrict litigation established for cancer lawsuits involving Allergan Inc.’s Biocell textured breast implants is preparing to get underway, following the issuance of an initial Case Management Order in the U.S. District Court, District of New Jersey. According to … Continue reading

Atrium Hernia Mesh Lawsuits: Parties Prepare to Make Final Bellwether Trial Selections

The federal court overseeing hernia mesh lawsuits involving Atrium Medical’s C-Qur products continues to prepare for upcoming bellwether trials. According to a Case Management Order issued in the U.S. District Court, District of New Hampshire on December 17th, the parties … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest